This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
Weight LossResearch vialGLP-1Weight lossOnce weeklySelf-mixAppetite
SEMA Self Mix (Semaglutide)
Long-acting GLP-1 agonist — slows gastric emptying and quietens appetite signalling.
R 1 170
10mg vial
Appetite controlActs on hypothalamic GLP-1 receptors to reduce hunger and food preoccupation.
Steady fat lossSTEP 1 trial showed -14.9% body weight at 68 weeks versus -2.4% on placebo.
Slower gastric emptyingFood leaves the stomach more slowly, extending satiety after meals.
Glucose-dependent insulinStimulates insulin release only when blood glucose is elevated.
Semaglutide is a synthetic GLP-1 receptor agonist — a long-acting analog of the gut hormone glucagon-like peptide 1. It binds the GLP-1 receptor, which slows gastric emptying, stimulates glucose-dependent insulin release, and reduces appetite signalling in the hypothalamus. "Self mix" refers to the format: lyophilised powder reconstituted with bacteriostatic water before subcutaneous injection.
More in Weight Loss
You might also like
Weight LossR 195
90 capsules
Natural Fat Burner
A daily botanical + thermogenic capsule designed to support metabolism and an active routine — from the Slender Living line.
View details →
Weight LossR 669
30 capsules
S30 Extreme Fat Burner
An extreme thermogenic fat-burner capsule — formulated for serious weight-loss routines and hard-training days.
View details →
Weight LossR 689
30 capsules
V30 Hardcore Fat Burner
A hardcore fat-burner capsule for advanced users — intense thermogenic support to push past plateaus.
View details →
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.